Global Acute Coronary Syndrome Market, By Type (Unstable Angina, ST-Elevation Myocardial Infarction, Non-ST-Elevation Myocardial Infarction, Others), Diagnosis (Blood Tests, Imaging, Stress Test, Others), Treatment (Medication, Surgery), End-Users (Hospitals and Clinics, Diagnostic Centers, Academic Institutes, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The acute coronary syndrome market is expected to witness market growth at a rate of 5.82% in the forecast period of 2021 to 2028 and is expected to reach USD 15,491.50 million by 2028. Data Bridge Market Research report on acute coronary syndrome market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in ageing population globally is escalating the growth of acute coronary syndrome market.
Acute coronary syndrome refers to a range of conditions related to sudden, reduced blood flow to the heart. It is known to be the medical condition requiring an immediate diagnosis and care. Chest pain, nausea, indigestion, dyspnea and heavy sweating are considered some of the common symptoms that are witnessed during acute coronary syndrome.
The growth in the prevalence of obesity among population and increasing geriatric population prone to such syndromes acts as the major factors driving the growth of acute coronary syndrome market. The increasing rate of lifestyle-associated disorders such as diabetes, rising cholesterol level among others and growing incidences of hypertension, growing adoption of drugs and smoking abuse accelerate the acute coronary syndrome market growth. The change in lifestyles of people, changing food habits and reduction in blood flow in the arteries causing medical condition further influence the acute coronary syndrome market. The growing awareness about the disease, the benefits of early diagnosis and treatments available among the population further also boost the acute coronary syndrome market. Additionally, growth of awareness regarding the products, growth in population, rise in healthcare expenditure and surge in healthcare expenditure positively affect the acute coronary syndrome market. Furthermore, technological advancement and innovations in the treatment facilities extend profitable opportunities to the acute coronary syndrome market players in the forecast period of 2021 to 2028.
On the other hand, less number of approved drugs is expected to obstruct the acute coronary syndrome market growth. The implementation of stringent government regulations associated with the drug approval is projected to challenge the acute coronary syndrome market in the forecast period of 2021-2028.
This acute coronary syndrome market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on acute coronary syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Acute Coronary Syndrome Market Scope and Market Size
The acute coronary syndrome market is segmented on the basis of type, diagnosis, treatment and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the acute coronary syndrome market is segmented into unstable angina, ST-elevation myocardial infarction, non-ST-elevation myocardial infarction and others.
- On the basis of diagnosis, the acute coronary syndrome market is segmented into blood tests, imaging, stress test and others. Imaging is further segmented into myocardial perfusion imaging (MPI), computerized tomography (CT), angiogram, echocardiogram, coronary angiogram and others.
- On the basis of treatment, the acute coronary syndrome market is segmented into medication and surgery. Medication is further segmented into thrombolytics, nitroglycerin, antiplatelet drugs, beta blockers and statins. Antiplatelet drugs are sub-segmented into aspirin, clopidogrel, prasugrel and others. Beta blockers are sub-segmented into metoprolol, nadolol and others. Statins are sub-segmented into atorvastatin, simvastatin and others. Surgery is further segmented into angioplasty and stenting, coronary bypass surgery and others.
- On the basis of end-users, the acute coronary syndrome market is segmented into hospitals and clinics, diagnostic centers, academic institutes and others.
Global Acute Coronary Syndrome Market Country Level Analysis
The acute coronary syndrome market is analyzed and market size insights and trends are provided by country, type, diagnosis, treatment and end-users as referenced above.
The countries covered in the global acute coronary syndrome market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America and Europe dominate the acute coronary syndrome market due to the rising awareness regarding acute coronary syndrome. Asia-Pacific is expected to witness the highest growth rate during the forecast period of 2021 to 2028 because of the increasing number of outsourcing, rising medical tourism, growing awareness about ACS and increasing disposable income in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The acute coronary syndrome market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for acute coronary syndrome market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the acute coronary syndrome market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Acute Coronary Syndrome Market Share Analysis
The acute coronary syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to acute coronary syndrome market.
The major players covered in the acute coronary syndrome market report are Teva Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories Ltd., Boehringer Ingelheim International GmbH, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Amgen Inc., AbbVie Inc., Portals Pharma, Inc., AstraZeneca, GlaxoSmithKline plc, Eli Lilly and Company, DAIICHI SANKYO COMPANY LIMITED, Sanofi, Daiichi Sankyo, Inc., Pfizer Inc., Baxter, DCVMN, Serum Institute of India Pvt. Ltd., Biogen among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Acute Coronary Syndrome Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.